Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...